MDIT Projected Dividend Yield

MEDITE Cancer Diagnostics Inc ( OTCBB : MDIT )

MEDITE Cancer Diagnostics is a medical technology company. Through its subsidiary, MEDITE Enterprises, Inc. (MEDITE) Co. is engaged in the development, engineering, manufacturing and marketing of medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. In the segment of histology consumables, Co. provides embedding cassettes, microscope slides, paraffin, staining solutions, reagents and other products. Some of the consumable products are MEDITE Enterprises, Inc. developments exclusively manufactured by or for Co. For the Cytology market, Co. provides products for the whole process, from cell collection over processing to diagnosis.

20 YEAR PERFORMANCE RESULTS